Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT-TRIM: FMT for Obesity and Glycemic Control
NCT02530385Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2016
- Primary completion
- Jun 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in obesity, insulin resistance (IR), sponsored by Massachusetts General Hospital. Started Jun 2016; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on NCT02530385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02530385.